Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 234

Results For "SEC"

3011 News Found

Sky announces the availability of its geko device on the Indian govt e-marketplace
Medical Device | April 07, 2022

Sky announces the availability of its geko device on the Indian govt e-marketplace

With this move, government hospitals across India can now access the geko device to prevent life-threatening blood clots, and address complications related to swelling following orthopaedic surgery and the healing of chronic wounds (leg ulcers)


JB Chemicals and Pharmaceuticals partners with Akshay Chaitanya to provide free lunch in hospitals
Sustainability | April 07, 2022

JB Chemicals and Pharmaceuticals partners with Akshay Chaitanya to provide free lunch in hospitals

Under this initiative, 700 meals will be provided every day to four hospitals in Mumbai


Indian pharma growth likely to moderate in FY23: ICRA
News | April 07, 2022

Indian pharma growth likely to moderate in FY23: ICRA

Headwinds related to pricing pressures and rising raw material costs will result in some contraction in margins in Q4 FY22 and FY23


Pristyn Care’s new app enables location-based discovery of doctors
Startup | April 06, 2022

Pristyn Care’s new app enables location-based discovery of doctors

An upgraded, state-of-the-art integrated app, helps easy discovery of expert surgeons for convenient in-clinic or online consultation


MilliporeSigma acquires MAST platform from Lonza
Biotech | April 06, 2022

MilliporeSigma acquires MAST platform from Lonza

MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies


ENTOD Pharma bullish on Macushield sales
News | April 06, 2022

ENTOD Pharma bullish on Macushield sales

Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision


Revenue growth to moderate, non-Covid-19 revenue to drive profitability
News | April 06, 2022

Revenue growth to moderate, non-Covid-19 revenue to drive profitability

Ind-Ra maintains a neutral outlook for healthcare in FY23


Alvotech and STADA pave way to launching Hukyndra
Biotech | April 06, 2022

Alvotech and STADA pave way to launching Hukyndra

All intellectual-property disputes related to the market entry of Alvotech’s AVT02 (adalimumab) in the U.S. and Europe are now resolved


Feedback Medical brings Bleepa to India
Digitisation | April 05, 2022

Feedback Medical brings Bleepa to India

Announces pilot project for rapid, remote diagnosis of tuberculosis


Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Biotech | April 05, 2022

Good business performance gives Boehringer Ingelheim tailwind for investment in R&D

R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)